National Health Investors, Inc. (NHI) Comparison with companies in other sectors?

National Health Investors, Inc. has a share price of 46.69M. You can analyze National Health Investors, Inc. (NHI) competitors across different market sectors through stock heatmaps.

What are NHI's NET and operating margins?

National Health Investors, Inc. (NHI) operating margin is around 0.54, and net profit margin is approximately 0.41 as of the latest reports.

In what way does NHI's earnings per share (EPS) trend reflect its financial momentum?

National Health Investors, Inc. (NHI) EPS is 3.16 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for National Health Investors, Inc. is 22.49, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for National Health Investors, Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for National Health Investors, Inc. like P/E which is 23.05, P/B which is 2.28, and PEG which is 18.09. Compare them with sector averages to evaluate if the stock is priced fairly.

National Health Investors, Inc.

NHI•NYSE

Real Estate

REIT - Healthcare Facilities

$71.10

$-0.04(-0.06%)

Fundamental Analysis of National Health Investors, Inc. (NHI)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$3.16

P/E Ratio

22.49

ROE

0.11%

Net Margin

0.41%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$3.32B

Shares OutstandingTotal number of shares issued

$46.69M

Book Value/ShareNet worth per share

$31.60

Revenue/ShareAnnual revenue per share

$7.50

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$3.16

Net MarginNet income as percentage of revenue

41.17%

Operating MarginOperating income as percentage of revenue

54.37%

ROEReturn on shareholders' equity

10.72%

ROAReturn on total assets

5.07%

ROCEReturn on capital employed

8.25%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$4.58

Cash/ShareCash and equivalents per share

$2.95

FCF YieldFree cash flow as percentage of market cap

6.30%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$3.60

Dividend YieldAnnual dividend as percentage of stock price

5.06%

Financial Ratios Analysis data is not available for NHIFinancial Ratios Analysis details for NHI are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for NHISector Benchmarking details for NHI are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for National Health Investors, Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of National Health Investors, Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account National Health Investors, Inc.'s unique business strengths and challenges.

Key Financial Metrics for National Health Investors, Inc.

For National Health Investors, Inc., essential financial indicators include EPS 3.16, PE 22.49, and ROE 0.11. These key ratios reveal insights into National Health Investors, Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare National Health Investors, Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of National Health Investors, Inc.

Metrics like Net Margin 41.17% and ROA 5.07% shed light on how well National Health Investors, Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether National Health Investors, Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of National Health Investors, Inc.

Using ratios such as P/B Ratio 2.28 and PEG Ratio 18.09, investors can assess whether National Health Investors, Inc. is appropriately valued based on its financials and growth potential. These figures, combined with National Health Investors, Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for National Health Investors, Inc.

Financial health indicators, such as Debt/Equity Ratio 0.89 and Cash Flow $4.58, provide a snapshot of National Health Investors, Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like National Health Investors, Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for National Health Investors, Inc.

Investing in National Health Investors, Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at National Health Investors, Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;